Traders Bet on 16 Nifty Swing with Long Straddle Amid West Asia Tensions
Consumer Sentiment Hits Fresh Record Low in May Amid Surging Gas Prices Linked to Iran Conflict
Arabica Coffee Futures Surge to Record High Amid USColombia Tariff Dispute Resolution
USChina Trade Rifts Persist at APEC After TrumpXi Summit
Bank Holiday Sunshine Drives Tourism Boost in Devon and Cornwall
Goldman Sachs Raises SP 500 Target Dismisses Bubble Fears
CTVA Q1 2026 Earnings Strong EPS Beat Drives Positive Investor Sentiment
FET Q1 2026 Earnings EPS Surprises to the Upside as Stock Pulls Back
OceanFirst Financial Corp OCFC Q1 2026 Earnings EPS Beat Amid Flat Revenue and Muted Market Response
Woodward Inc WWD Q1 2026 Earnings EPS Beats Estimates by 782 as Stock Edges Lower
SILA Q4 2025 Earnings EPS Misses Estimates Despite Positive Stock Movement
AMP Q1 2026 Earnings EPS Beats Estimates by 923 as Wealth Management Segment Drives Results
T3 Defense Inc DFNS Surges Over 18 as Defense Sector Momentum Builds
Fifth Era Acquisition Corp I Rights FERAR Faces Selling Pressure Tests Key Support at 028
MKDWELL Tech Inc MKDW Surges 465 as Shares Test Key Resistance Near 852
Eshallgo Inc EHGO Surges 17 as Buying Momentum Returns
Osisko Development Corp ODV Declines Approaching Critical Support Level
IRFC Secures 13527 Crore Refinancing Deal for Hyderabad Metro Expansion
KR Q1 2026 Earnings EPS Beat Fails to Inspire Shares Slip
ING Group Slips 05 as Shares Test Key Support at 2897
INCR Q2 2023 Earnings EPS Surprises 2868 Above Estimates Despite Negative Stock Reaction
BNC Q3 2023 Earnings Net Loss Per Share of 010 as Company Streamlines Operations
Biglari Holdings BH Q1 2025 Earnings Strong EPS Amid Quiet Market Reception
Saratoga Investment Corp SAR Q1 2026 Earnings Wide EPS Miss on Weak Portfolio Performance Stock Edges Higher
Mastercard Q1 2026 Earnings EPS Surpasses Estimates Despite Revenue Uncertainty Stock Slips
CPNG Q1 2026 Earnings EPS Misses by Over 200 Amid Strategic Investments Shares Rise 277
DRTS Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Faces Challenges